检索结果 - Lee, Jeong-Ok
- Showing 1 - 20 results of 58
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remissio... 由 Byun, Ja Min, Shin, Dong-Yeop, Koh, Youngil, Hong, Junshik, Kim, Inho, Yoon, Sung-Soo, Bang, Soo-Mee, Lee, Jeong-Ok
出版 2021Text -
13
-
14
How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution 由 Keam, Bhumsuk, Kim, Dong-Wan, Park, Jin Hyun, Lee, Jeong-Ok, Kim, Tae Min, Lee, Se-Hoon, Chung, Doo Hyun, Heo, Dae Seog
出版 2013Text -
15
-
16
-
17
-
18
-
19
Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients wit... 由 Choi, Mihong, Heo, Ja Yoon, Shin, Dong-Yeop, Lee, Ji Yun, Koh, Youngil, Hong, Junshik, Kim, Inho, Yoon, Sung-Soo, Lee, Jeong-Ok, Bang, Soo-Mee
出版 2020Text -
20
A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas 由 Kim, Miso, Lee, Jeong-Ok, Koh, Jiwon, Kim, Tae Min, Lee, Ji Yun, Jeon, Yoon Kyung, Keam, Bhumsuk, Kim, Dong-Wan, Lee, Jong Seok, Heo, Dae Seog
出版 2021Text